Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Pemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma

Pemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma PMT in MPM patients is non-toxic, well tolerated and although promising effects on TTP and OS are demonstrated, the effectiveness of PMT should be further explored in a prospective randomized clinical trial. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Pemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma

Journal of Thoracic Oncology , Volume 1 (1) – Jan 1, 2006

Loading next page...
 
/lp/wolters-kluwer-health/pemetrexed-maintenance-therapy-in-patients-with-malignant-pleural-bYm9TyjQbW

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

PMT in MPM patients is non-toxic, well tolerated and although promising effects on TTP and OS are demonstrated, the effectiveness of PMT should be further explored in a prospective randomized clinical trial.

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Jan 1, 2006

There are no references for this article.